TAK-653 vs Selank
Side-by-side comparison of TAK-653 and Selank: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
TAK-653
Selank
TAK-653
TAK-653 is a novel positive allosteric modulator (PAM) of AMPA-type glutamate receptors developed by Takeda Pharmaceuticals. It enhances glutamatergic neurotransmission without directly activating the receptor, offering…
Lowest listed price: $79.99 across 1 listing
Full TAK-653 profileSelank
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin…
Lowest listed price: $25.00 across 6 listings
Full Selank profileSide-by-side comparison
| Attribute | TAK-653 | Selank |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Phase II Clinical Trials | Approved (Russia, as anxiolytic and nootropic medication) |
| Mechanism of Action | TAK-653 acts as a positive allosteric modulator (PAM) of AMPA receptors, binding to a site distinct from the glutamate binding site. It increases the receptor's sensitivity to glutamate, improving excitatory postsynaptic currents (EPSCs) and promoting… | Primary Mechanism: Multi-System Neurochemical Modulation Selank does not have a single clean receptor-binding mechanism. Unlike benzodiazepines (GABA-A positive allosteric modulators), SSRIs (serotonin reuptake inhibition), or buspirone (5-HT1A partial… |
| Half-Life | 6-10 hours (estimated) | ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation) |
| Typical Dose Range | 0.1 mg - 6 mg | 250-750 mcg intranasal daily (0.15% solution: 2-3 drops per nostril 2-3x daily); typical course is 14-21 days |
| Dosing Frequency | Once daily | Intranasal 1–3 times daily |
| Administration | Oral | Intranasal |
| Side Effects | Headache, mild nausea, insomnia (if taken late in day), potential overstimulation at higher doses. Seizure risk at supratherapeutic doses due to glutamatergic mechanism. Mild anxiety or agitation reported in some users. | Overall Safety Profile Selank has one of the best safety profiles in the anxiolytic space. Over 15+ years of Russian clinical use and research, the compound has been associated with essentially no serious adverse events at therapeutic doses. This compares… |
| Molecular Weight | 282.27 | 751.9 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price tracking
Price History
5 data points- OF
- Half Nattys
- Ion Peptide
- BHG Labs
TAK-653: potential benefits
- Cognitive enhancement and improved learning
- Antidepressant effects (treatment-resistant depression)
- Enhanced synaptic plasticity and LTP
- Increased BDNF expression
- Improved working memory and executive function
- Potential neuroprotective properties
Selank: potential benefits
- Anxiolytic effects comparable to benzodiazepines but without sedation or dependence in Russian clinical trials (PMID: 18454096)
- Positive allosteric modulation of brain GABA receptors through a non-benzodiazepine binding site (PMID: 30255741)
- Immunomodulation via Th1/Th2 cytokine balance and IL-6 regulation in patients with anxiety-asthenic disorders (PMID: 18577961)
- Cognitive and memory support linked to BDNF upregulation in the hippocampus in preclinical models (PMID: 18841804)
- Modulation of the endogenous enkephalin-opioid system supporting mood and stress tolerance (PMID: 22550852)
- Anti-inflammatory and adaptogenic effects through normalization of stress-induced cytokine dysregulation
- Non-addictive anxiolytic profile - no tolerance, withdrawal, or dependence reported across years of Russian clinical use
Frequently asked
What's the difference between TAK-653 and Selank?
TAK-653 is a nootropics that tak-653 acts as a positive allosteric modulator (pam) of ampa receptors, binding to a site distinct from the glutamate binding site. it increases the receptor's sensitivity to…. Selank is a nootropics that primary mechanism: multi-system neurochemical modulation selank does not have a single clean receptor-binding mechanism. unlike benzodiazepines (gaba-a positive allosteric…. The two differ in mechanism, half-life (6-10 hours (estimated) vs ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation)), and typical dose range.
Which has the longer half-life, TAK-653 or Selank?
TAK-653 has a half-life of 6-10 hours (estimated). Selank has a half-life of ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, TAK-653 or Selank?
Lowest listed price on BodyHackGuide: TAK-653 from $79.99, Selank from $25.00. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack TAK-653 and Selank?
Few pairs of research compounds have been tested together in people, so for most pairs no trial shows whether combining them is safe or adds anything. Each compound's page lists its side effects and the interactions in our record, and the table on this page puts their side effects side by side.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy TAK-653 or Selank
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.